EcoDrugPlus

Integrin Beta 3b

Ensembl ID : ENSCHAG00000024921
Gene Symbol: ITGB3B
1 Cross references
195 Possible Orthologues:

Integrin Beta-2-Like

Ensembl ID : ENSCHAG00000015938
Gene Symbol: LOC105907972
2 Cross references
185 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSCHAG00000005487
Gene Symbol: ITGA4
1 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSCHAG00000018349
Gene Symbol: ITGA5
1 Cross references
196 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSCHAG00000012537
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSCHAG00000017384
Gene Symbol: ITGAV
1 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSCHAG00000006240
Gene Symbol: ITGB5
3 Cross references
165 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSCHAG00000008838
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSCHAG00000022224
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Integrin, Alpha 2b

Ensembl ID : ENSCHAG00000019890
Gene Symbol: ITGA2B
1 Cross references
191 Possible Orthologues:

Integrin, Beta 1b

Ensembl ID : ENSCHAG00000005032
Gene Symbol: ITGB1B
1 Cross references
230 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSCHAG00000018882
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).